Industry Research Reports
Home > Reports > Chemical & Material > Global Neomycin Sulfate API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Neomycin Sulfate API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Chemical & Material
Published Date: 2025-02-14
Pages: 91 Pages
Report ld: 3830004
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Neomycin Sulfate API Market Size(US$)
CAGR 2025-2031
6.5%
Market Size,2031
USD 283
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 194 million
Market Forecast in 2031(Value)
US$ 283 million
CAGR
6.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Neomycin Sulfate API market size was US$ 183 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
The API industry is an important part of the pharmaceutical industry and involves the primary production stage of drugs. In this industry, chemical, biological or other technological methods are used to synthesize, extract or manufacture the active ingredients of drugs, which are called active ingredients. APIs are the core components of medicines, and their quality and purity are critical to the safety and effectiveness of medicines. The API industry includes many aspects such as drug research and development, production, supervision and quality control. It is one of the key industries supporting the medical care system and has an important impact on human health. The development of this industry is affected by various factors such as technological progress, regulatory changes and market demand, and is highly complex and competitive.
The global Neomycin Sulfate API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neomycin Sulfate API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
By Company
- Yichang Three Gorges Pharmaceutical
- Shandong Saito Biotechnology
- Xinyu Pharmaceutical
- Renfu Medicine
- Manus Aktteva Biopharma
- DKSH
- Fagron Industry
- Caesar & Loretz GmbH
- Syndesmos
- B Joshi Agrochem Pharma
- Crystal Pharma
- Sichuan Long March Pharmaceuticals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Veterinary Use
- Human Use
Segment by Application
- Biopharmaceutical
- Research
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Neomycin Sulfate API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Neomycin Sulfate API manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neomycin Sulfate API revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Neomycin Sulfate API Product Scope
1.2 Neomycin Sulfate API by Type
1.2.1 Global Neomycin Sulfate API Sales by Type (2020 & 2024 & 2031)
1.2.2 Veterinary Use
1.2.3 Human Use
1.3 Neomycin Sulfate API by Application
1.3.1 Global Neomycin Sulfate API Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Biopharmaceutical
1.3.3 Research
1.4 Global Neomycin Sulfate API Market Estimates and Forecasts (2020-2031)
1.4.1 Global Neomycin Sulfate API Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Neomycin Sulfate API Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Neomycin Sulfate API Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Neomycin Sulfate API Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Neomycin Sulfate API Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Neomycin Sulfate API Sales Market Share by Region (2020-2025)
2.2.2 Global Neomycin Sulfate API Revenue Market Share by Region (2020-2025)
2.3 Global Neomycin Sulfate API Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Neomycin Sulfate API Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Neomycin Sulfate API Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Neomycin Sulfate API Market Size and Prospective (2020-2031)
2.4.2 Europe Neomycin Sulfate API Market Size and Prospective (2020-2031)
2.4.3 China Neomycin Sulfate API Market Size and Prospective (2020-2031)
2.4.4 Japan Neomycin Sulfate API Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Neomycin Sulfate API Historic Market Review by Type (2020-2025)
3.1.1 Global Neomycin Sulfate API Sales by Type (2020-2025)
3.1.2 Global Neomycin Sulfate API Revenue by Type (2020-2025)
3.1.3 Global Neomycin Sulfate API Price by Type (2020-2025)
3.2 Global Neomycin Sulfate API Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Neomycin Sulfate API Sales Forecast by Type (2026-2031)
3.2.2 Global Neomycin Sulfate API Revenue Forecast by Type (2026-2031)
3.2.3 Global Neomycin Sulfate API Price Forecast by Type (2026-2031)
3.3 Different Types Neomycin Sulfate API Representative Players
4 Global Market Size by Application
4.1 Global Neomycin Sulfate API Historic Market Review by Application (2020-2025)
4.1.1 Global Neomycin Sulfate API Sales by Application (2020-2025)
4.1.2 Global Neomycin Sulfate API Revenue by Application (2020-2025)
4.1.3 Global Neomycin Sulfate API Price by Application (2020-2025)
4.2 Global Neomycin Sulfate API Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Neomycin Sulfate API Sales Forecast by Application (2026-2031)
4.2.2 Global Neomycin Sulfate API Revenue Forecast by Application (2026-2031)
4.2.3 Global Neomycin Sulfate API Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Neomycin Sulfate API Application
5 Competition Landscape by Players
5.1 Global Neomycin Sulfate API Sales by Players (2020-2025)
5.2 Global Top Neomycin Sulfate API Players by Revenue (2020-2025)
5.3 Global Neomycin Sulfate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neomycin Sulfate API as of 2024)
5.4 Global Neomycin Sulfate API Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Neomycin Sulfate API, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Neomycin Sulfate API, Product Type & Application
5.7 Global Key Manufacturers of Neomycin Sulfate API, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Neomycin Sulfate API Sales by Company
6.1.1.1 North America Neomycin Sulfate API Sales by Company (2020-2025)
6.1.1.2 North America Neomycin Sulfate API Revenue by Company (2020-2025)
6.1.2 North America Neomycin Sulfate API Sales Breakdown by Type (2020-2025)
6.1.3 North America Neomycin Sulfate API Sales Breakdown by Application (2020-2025)
6.1.4 North America Neomycin Sulfate API Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Neomycin Sulfate API Sales by Company
6.2.1.1 Europe Neomycin Sulfate API Sales by Company (2020-2025)
6.2.1.2 Europe Neomycin Sulfate API Revenue by Company (2020-2025)
6.2.2 Europe Neomycin Sulfate API Sales Breakdown by Type (2020-2025)
6.2.3 Europe Neomycin Sulfate API Sales Breakdown by Application (2020-2025)
6.2.4 Europe Neomycin Sulfate API Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Neomycin Sulfate API Sales by Company
6.3.1.1 China Neomycin Sulfate API Sales by Company (2020-2025)
6.3.1.2 China Neomycin Sulfate API Revenue by Company (2020-2025)
6.3.2 China Neomycin Sulfate API Sales Breakdown by Type (2020-2025)
6.3.3 China Neomycin Sulfate API Sales Breakdown by Application (2020-2025)
6.3.4 China Neomycin Sulfate API Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Neomycin Sulfate API Sales by Company
6.4.1.1 Japan Neomycin Sulfate API Sales by Company (2020-2025)
6.4.1.2 Japan Neomycin Sulfate API Revenue by Company (2020-2025)
6.4.2 Japan Neomycin Sulfate API Sales Breakdown by Type (2020-2025)
6.4.3 Japan Neomycin Sulfate API Sales Breakdown by Application (2020-2025)
6.4.4 Japan Neomycin Sulfate API Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Yichang Three Gorges Pharmaceutical
7.1.1 Yichang Three Gorges Pharmaceutical Company Information
7.1.2 Yichang Three Gorges Pharmaceutical Business Overview
7.1.3 Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Products Offered
7.1.5 Yichang Three Gorges Pharmaceutical Recent Development
7.2 Shandong Saito Biotechnology
7.2.1 Shandong Saito Biotechnology Company Information
7.2.2 Shandong Saito Biotechnology Business Overview
7.2.3 Shandong Saito Biotechnology Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Shandong Saito Biotechnology Neomycin Sulfate API Products Offered
7.2.5 Shandong Saito Biotechnology Recent Development
7.3 Xinyu Pharmaceutical
7.3.1 Xinyu Pharmaceutical Company Information
7.3.2 Xinyu Pharmaceutical Business Overview
7.3.3 Xinyu Pharmaceutical Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Xinyu Pharmaceutical Neomycin Sulfate API Products Offered
7.3.5 Xinyu Pharmaceutical Recent Development
7.4 Renfu Medicine
7.4.1 Renfu Medicine Company Information
7.4.2 Renfu Medicine Business Overview
7.4.3 Renfu Medicine Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Renfu Medicine Neomycin Sulfate API Products Offered
7.4.5 Renfu Medicine Recent Development
7.5 Manus Aktteva Biopharma
7.5.1 Manus Aktteva Biopharma Company Information
7.5.2 Manus Aktteva Biopharma Business Overview
7.5.3 Manus Aktteva Biopharma Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Manus Aktteva Biopharma Neomycin Sulfate API Products Offered
7.5.5 Manus Aktteva Biopharma Recent Development
7.6 DKSH
7.6.1 DKSH Company Information
7.6.2 DKSH Business Overview
7.6.3 DKSH Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.6.4 DKSH Neomycin Sulfate API Products Offered
7.6.5 DKSH Recent Development
7.7 Fagron Industry
7.7.1 Fagron Industry Company Information
7.7.2 Fagron Industry Business Overview
7.7.3 Fagron Industry Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Fagron Industry Neomycin Sulfate API Products Offered
7.7.5 Fagron Industry Recent Development
7.8 Caesar & Loretz GmbH
7.8.1 Caesar & Loretz GmbH Company Information
7.8.2 Caesar & Loretz GmbH Business Overview
7.8.3 Caesar & Loretz GmbH Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Caesar & Loretz GmbH Neomycin Sulfate API Products Offered
7.8.5 Caesar & Loretz GmbH Recent Development
7.9 Syndesmos
7.9.1 Syndesmos Company Information
7.9.2 Syndesmos Business Overview
7.9.3 Syndesmos Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Syndesmos Neomycin Sulfate API Products Offered
7.9.5 Syndesmos Recent Development
7.10 B Joshi Agrochem Pharma
7.10.1 B Joshi Agrochem Pharma Company Information
7.10.2 B Joshi Agrochem Pharma Business Overview
7.10.3 B Joshi Agrochem Pharma Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.10.4 B Joshi Agrochem Pharma Neomycin Sulfate API Products Offered
7.10.5 B Joshi Agrochem Pharma Recent Development
7.11 Crystal Pharma
7.11.1 Crystal Pharma Company Information
7.11.2 Crystal Pharma Business Overview
7.11.3 Crystal Pharma Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Crystal Pharma Neomycin Sulfate API Products Offered
7.11.5 Crystal Pharma Recent Development
7.12 Sichuan Long March Pharmaceuticals
7.12.1 Sichuan Long March Pharmaceuticals Company Information
7.12.2 Sichuan Long March Pharmaceuticals Business Overview
7.12.3 Sichuan Long March Pharmaceuticals Neomycin Sulfate API Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Sichuan Long March Pharmaceuticals Neomycin Sulfate API Products Offered
7.12.5 Sichuan Long March Pharmaceuticals Recent Development
8 Neomycin Sulfate API Manufacturing Cost Analysis
8.1 Neomycin Sulfate API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Neomycin Sulfate API
8.4 Neomycin Sulfate API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Neomycin Sulfate API Distributors List
9.3 Neomycin Sulfate API Customers
10 Neomycin Sulfate API Market Dynamics
10.1 Neomycin Sulfate API Industry Trends
10.2 Neomycin Sulfate API Market Drivers
10.3 Neomycin Sulfate API Market Challenges
10.4 Neomycin Sulfate API Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Neomycin Sulfate API Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Neomycin Sulfate API Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Neomycin Sulfate API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Neomycin Sulfate API Sales (Tons) by Region (2020-2025)
Table 5. Global Neomycin Sulfate API Sales Market Share by Region (2020-2025)
Table 6. Global Neomycin Sulfate API Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Neomycin Sulfate API Revenue Share by Region (2020-2025)
Table 8. Global Neomycin Sulfate API Sales (Tons) Forecast by Region (2026-2031)
Table 9. Global Neomycin Sulfate API Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Neomycin Sulfate API Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Neomycin Sulfate API Revenue Share Forecast by Region (2026-2031)
Table 12. Global Neomycin Sulfate API Sales by Type (Tons) & (2020-2025)
Table 13. Global Neomycin Sulfate API Sales Share by Type (2020-2025)
Table 14. Global Neomycin Sulfate API Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Neomycin Sulfate API Price by Type (US$/Ton) & (2020-2025)
Table 16. Global Neomycin Sulfate API Sales by Type (Tons) & (2026-2031)
Table 17. Global Neomycin Sulfate API Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Neomycin Sulfate API Price by Type (US$/Ton) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Neomycin Sulfate API Sales by Application (Tons) & (2020-2025)
Table 21. Global Neomycin Sulfate API Sales Share by Application (2020-2025)
Table 22. Global Neomycin Sulfate API Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Neomycin Sulfate API Price by Application (US$/Ton) & (2020-2025)
Table 24. Global Neomycin Sulfate API Sales by Application (Tons) & (2026-2031)
Table 25. Global Neomycin Sulfate API Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Neomycin Sulfate API Price by Application (US$/Ton) & (2026-2031)
Table 27. New Sources of Growth in Neomycin Sulfate API Application
Table 28. Global Neomycin Sulfate API Sales by Company (Tons) & (2020-2025)
Table 29. Global Neomycin Sulfate API Sales Share by Company (2020-2025)
Table 30. Global Neomycin Sulfate API Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Neomycin Sulfate API Revenue Share by Company (2020-2025)
Table 32. Global Neomycin Sulfate API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neomycin Sulfate API as of 2024)
Table 33. Global Market Neomycin Sulfate API Average Price by Company (US$/Ton) & (2020-2025)
Table 34. Global Key Manufacturers of Neomycin Sulfate API, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Neomycin Sulfate API, Product Type & Application
Table 36. Global Key Manufacturers of Neomycin Sulfate API, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Neomycin Sulfate API Sales by Company (2020-2025) & (Tons)
Table 39. North America Neomycin Sulfate API Sales Market Share by Company (2020-2025)
Table 40. North America Neomycin Sulfate API Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Neomycin Sulfate API Revenue Market Share by Company (2020-2025)
Table 42. North America Neomycin Sulfate API Sales by Type (2020-2025) & (Tons)
Table 43. North America Neomycin Sulfate API Sales Market Share by Type (2020-2025)
Table 44. North America Neomycin Sulfate API Sales by Application (2020-2025) & (Tons)
Table 45. North America Neomycin Sulfate API Sales Market Share by Application (2020-2025)
Table 46. Europe Neomycin Sulfate API Sales by Company (2020-2025) & (Tons)
Table 47. Europe Neomycin Sulfate API Sales Market Share by Company (2020-2025)
Table 48. Europe Neomycin Sulfate API Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Neomycin Sulfate API Revenue Market Share by Company (2020-2025)
Table 50. Europe Neomycin Sulfate API Sales by Type (2020-2025) & (Tons)
Table 51. Europe Neomycin Sulfate API Sales Market Share by Type (2020-2025)
Table 52. Europe Neomycin Sulfate API Sales by Application (2020-2025) & (Tons)
Table 53. Europe Neomycin Sulfate API Sales Market Share by Application (2020-2025)
Table 54. China Neomycin Sulfate API Sales by Company (2020-2025) & (Tons)
Table 55. China Neomycin Sulfate API Sales Market Share by Company (2020-2025)
Table 56. China Neomycin Sulfate API Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Neomycin Sulfate API Revenue Market Share by Company (2020-2025)
Table 58. China Neomycin Sulfate API Sales by Type (2020-2025) & (Tons)
Table 59. China Neomycin Sulfate API Sales Market Share by Type (2020-2025)
Table 60. China Neomycin Sulfate API Sales by Application (2020-2025) & (Tons)
Table 61. China Neomycin Sulfate API Sales Market Share by Application (2020-2025)
Table 62. Japan Neomycin Sulfate API Sales by Company (2020-2025) & (Tons)
Table 63. Japan Neomycin Sulfate API Sales Market Share by Company (2020-2025)
Table 64. Japan Neomycin Sulfate API Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Neomycin Sulfate API Revenue Market Share by Company (2020-2025)
Table 66. Japan Neomycin Sulfate API Sales by Type (2020-2025) & (Tons)
Table 67. Japan Neomycin Sulfate API Sales Market Share by Type (2020-2025)
Table 68. Japan Neomycin Sulfate API Sales by Application (2020-2025) & (Tons)
Table 69. Japan Neomycin Sulfate API Sales Market Share by Application (2020-2025)
Table 70. Yichang Three Gorges Pharmaceutical Company Information
Table 71. Yichang Three Gorges Pharmaceutical Description and Business Overview
Table 72. Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Product
Table 74. Yichang Three Gorges Pharmaceutical Recent Development
Table 75. Shandong Saito Biotechnology Company Information
Table 76. Shandong Saito Biotechnology Description and Business Overview
Table 77. Shandong Saito Biotechnology Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Shandong Saito Biotechnology Neomycin Sulfate API Product
Table 79. Shandong Saito Biotechnology Recent Development
Table 80. Xinyu Pharmaceutical Company Information
Table 81. Xinyu Pharmaceutical Description and Business Overview
Table 82. Xinyu Pharmaceutical Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Xinyu Pharmaceutical Neomycin Sulfate API Product
Table 84. Xinyu Pharmaceutical Recent Development
Table 85. Renfu Medicine Company Information
Table 86. Renfu Medicine Description and Business Overview
Table 87. Renfu Medicine Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Renfu Medicine Neomycin Sulfate API Product
Table 89. Renfu Medicine Recent Development
Table 90. Manus Aktteva Biopharma Company Information
Table 91. Manus Aktteva Biopharma Description and Business Overview
Table 92. Manus Aktteva Biopharma Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Manus Aktteva Biopharma Neomycin Sulfate API Product
Table 94. Manus Aktteva Biopharma Recent Development
Table 95. DKSH Company Information
Table 96. DKSH Description and Business Overview
Table 97. DKSH Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. DKSH Neomycin Sulfate API Product
Table 99. DKSH Recent Development
Table 100. Fagron Industry Company Information
Table 101. Fagron Industry Description and Business Overview
Table 102. Fagron Industry Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Fagron Industry Neomycin Sulfate API Product
Table 104. Fagron Industry Recent Development
Table 105. Caesar & Loretz GmbH Company Information
Table 106. Caesar & Loretz GmbH Description and Business Overview
Table 107. Caesar & Loretz GmbH Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Caesar & Loretz GmbH Neomycin Sulfate API Product
Table 109. Caesar & Loretz GmbH Recent Development
Table 110. Syndesmos Company Information
Table 111. Syndesmos Description and Business Overview
Table 112. Syndesmos Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Syndesmos Neomycin Sulfate API Product
Table 114. Syndesmos Recent Development
Table 115. B Joshi Agrochem Pharma Company Information
Table 116. B Joshi Agrochem Pharma Description and Business Overview
Table 117. B Joshi Agrochem Pharma Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. B Joshi Agrochem Pharma Neomycin Sulfate API Product
Table 119. B Joshi Agrochem Pharma Recent Development
Table 120. Crystal Pharma Company Information
Table 121. Crystal Pharma Description and Business Overview
Table 122. Crystal Pharma Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. Crystal Pharma Neomycin Sulfate API Product
Table 124. Crystal Pharma Recent Development
Table 125. Sichuan Long March Pharmaceuticals Company Information
Table 126. Sichuan Long March Pharmaceuticals Description and Business Overview
Table 127. Sichuan Long March Pharmaceuticals Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Sichuan Long March Pharmaceuticals Neomycin Sulfate API Product
Table 129. Sichuan Long March Pharmaceuticals Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Neomycin Sulfate API Distributors List
Table 133. Neomycin Sulfate API Customers List
Table 134. Neomycin Sulfate API Market Trends
Table 135. Neomycin Sulfate API Market Drivers
Table 136. Neomycin Sulfate API Market Challenges
Table 137. Neomycin Sulfate API Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Neomycin Sulfate API Product Picture
Figure 2. Global Neomycin Sulfate API Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Neomycin Sulfate API Sales Market Share by Type in 2024 & 2031
Figure 4. Veterinary Use Product Picture
Figure 5. Human Use Product Picture
Figure 6. Global Neomycin Sulfate API Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Neomycin Sulfate API Sales Market Share by Application in 2024 & 2031
Figure 8. Biopharmaceutical Examples
Figure 9. Research Examples
Figure 10. Global Neomycin Sulfate API Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Neomycin Sulfate API Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Neomycin Sulfate API Sales (Tons) Growth Rate (2020-2031)
Figure 13. Global Neomycin Sulfate API Price Trends Growth Rate (2020-2031) & (US$/Ton)
Figure 14. Neomycin Sulfate API Report Years Considered
Figure 15. Global Market Neomycin Sulfate API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Neomycin Sulfate API Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Neomycin Sulfate API Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Neomycin Sulfate API Sales (Tons) Growth Rate (2020-2031)
Figure 19. Europe Neomycin Sulfate API Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Neomycin Sulfate API Sales (Tons) Growth Rate (2020-2031)
Figure 21. China Neomycin Sulfate API Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China Neomycin Sulfate API Sales (Tons) Growth Rate (2020-2031)
Figure 23. Japan Neomycin Sulfate API Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Japan Neomycin Sulfate API Sales (Tons) Growth Rate (2020-2031)
Figure 25. Global Neomycin Sulfate API Revenue Share by Type (2020-2025)
Figure 26. Global Neomycin Sulfate API Sales Share by Type (2026-2031)
Figure 27. Global Neomycin Sulfate API Revenue Share by Type (2026-2031)
Figure 28. Global Neomycin Sulfate API Revenue Share by Application (2020-2025)
Figure 29. Global Neomycin Sulfate API Revenue Growth Rate by Application in 2020 & 2024
Figure 30. Global Neomycin Sulfate API Sales Share by Application (2026-2031)
Figure 31. Global Neomycin Sulfate API Revenue Share by Application (2026-2031)
Figure 32. Global Neomycin Sulfate API Sales Share by Company (2024)
Figure 33. Global Neomycin Sulfate API Revenue Share by Company (2024)
Figure 34. Global 5 Largest Neomycin Sulfate API Players Market Share by Revenue in Neomycin Sulfate API: 2020 & 2024
Figure 35. Neomycin Sulfate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Manufacturing Cost Structure of Neomycin Sulfate API
Figure 37. Manufacturing Process Analysis of Neomycin Sulfate API
Figure 38. Neomycin Sulfate API Industrial Chain
Figure 39. Channels of Distribution (Direct Vs Distribution)
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Neomycin Sulfate API market size from 2025 to 2031?
The annual compound growth rate of the global Neomycin Sulfate API market is 6.5% 2025 to 2031.
What was the global market size of Neomycin Sulfate API in 2025?
What was the global market size of Neomycin Sulfate API in 2031?
Which region is expected to have the highest market share?
Which companies rank high in the global Neomycin Sulfate API market?
Related Reports
Global Neomycin Sulfate API Market Research Report 2026
The global Neomycin Sulfate API market was valued at US$ 194 million in 2025 and is anticipated to reach US$ 299 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 143
USD 2900.00
(Single User License)
Neomycin Sulfate API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neomycin Sulfate API was estimated to be worth US$ 194 million in 2025 and is projected to reach US$ 299 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 116
USD 3950.00
(Single User License)
Global Neomycin Sulfate API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neomycin Sulfate API market is projected to grow from US$ 183 million in 2024 to US$ 283 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 168
USD 4900.00
(Single User License)
Neomycin Sulfate API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neomycin Sulfate API was estimated to be worth US$ 183 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 126
USD 3950.00
(Single User License)
Global Neomycin Sulfate API Market Research Report 2025
The global market for Neomycin Sulfate API was valued at US$ 183 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-02-14
Pages: 102
USD 2900.00
(Single User License)
Global Neomycin Sulfate API Market Insights, Forecast to 2030
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
Published Date: 2024-04-26
Pages: 113
USD 4900.00
(Single User License)
Global Neomycin Sulfate API Market Research Report 2024
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
Published Date: 2024-01-17
Pages: 97
USD 2900.00
(Single User License)
Global Neomycin Sulfate API Market Research Report 2026
The global Neomycin Sulfate API market was valued at US$ 194 million in 2025 and is anticipated to reach US$ 299 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-02-02
Pages: 143
USD 2900.00 (Single User License)Neomycin Sulfate API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neomycin Sulfate API was estimated to be worth US$ 194 million in 2025 and is projected to reach US$ 299 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-02-02
Pages: 116
USD 3950.00 (Single User License)Global Neomycin Sulfate API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neomycin Sulfate API market is projected to grow from US$ 183 million in 2024 to US$ 283 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 168
USD 4900.00 (Single User License)Neomycin Sulfate API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neomycin Sulfate API was estimated to be worth US$ 183 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 126
USD 3950.00 (Single User License)Global Neomycin Sulfate API Market Research Report 2025
The global market for Neomycin Sulfate API was valued at US$ 183 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-02-14
Pages: 102
USD 2900.00 (Single User License)Global Neomycin Sulfate API Market Insights, Forecast to 2030
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
Published: 2024-04-26
Pages: 113
USD 4900.00 (Single User License)Global Neomycin Sulfate API Market Research Report 2024
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
Published: 2024-01-17
Pages: 97
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now